258 related articles for article (PubMed ID: 34698864)
1. 12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors.
Satomi K; Takami H; Fukushima S; Yamashita S; Matsushita Y; Nakazato Y; Suzuki T; Tanaka S; Mukasa A; Saito N; Kanamori M; Kumabe T; Tominaga T; Kobayashi K; Nagane M; Iuchi T; Yoshimoto K; Tamura K; Maehara T; Sakai K; Sugiyama K; Yokogami K; Takeshima H; Nonaka M; Asai A; Ushijima T; Matsutani M; Nishikawa R; Ichimura K
Neuro Oncol; 2022 May; 24(5):834-846. PubMed ID: 34698864
[TBL] [Abstract][Full Text] [Related]
2. Distinct patterns of copy number alterations may predict poor outcome in central nervous system germ cell tumors.
Takami H; Satomi K; Fukuoka K; Nakamura T; Tanaka S; Mukasa A; Saito N; Suzuki T; Yanagisawa T; Sugiyama K; Kanamori M; Kumabe T; Tominaga T; Tamura K; Maehara T; Nonaka M; Asai A; Yokogami K; Takeshima H; Iuchi T; Kobayashi K; Yoshimoto K; Sakai K; Nakazato Y; Matsutani M; Nagane M; Nishikawa R; Ichimura K
Sci Rep; 2023 Sep; 13(1):15760. PubMed ID: 37735187
[TBL] [Abstract][Full Text] [Related]
3. PD-L1 and PD-1 expression in pediatric central nervous system germ cell tumors.
Woods JK; Lidov HG; Ligon KL; Santagata S; Chi SN; Yeo KK; Alexandrescu S
Mod Pathol; 2022 Dec; 35(12):1770-1774. PubMed ID: 36057740
[TBL] [Abstract][Full Text] [Related]
4. Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy.
Ichimura K; Fukushima S; Totoki Y; Matsushita Y; Otsuka A; Tomiyama A; Niwa T; Takami H; Nakamura T; Suzuki T; Fukuoka K; Yanagisawa T; Mishima K; Nakazato Y; Hosoda F; Narita Y; Shibui S; Yoshida A; Mukasa A; Saito N; Kumabe T; Kanamori M; Tominaga T; Kobayashi K; Shimizu S; Nagane M; Iuchi T; Mizoguchi M; Yoshimoto K; Tamura K; Maehara T; Sugiyama K; Nakada M; Sakai K; Kanemura Y; Nonaka M; Asai A; Yokogami K; Takeshima H; Kawahara N; Takayama T; Yao M; Kato M; Nakamura H; Hama N; Sakai R; Ushijima T; Matsutani M; Shibata T; Nishikawa R;
Acta Neuropathol; 2016 Jun; 131(6):889-901. PubMed ID: 26956871
[TBL] [Abstract][Full Text] [Related]
5. Multi-institutional analysis of central nervous system germ cell tumors in patients with Down syndrome.
Harris MK; Graham RT; Cappellano AM; Margol AS; Michaiel G; Crawford JR; Ioakeim-Ioannidou M; Stanek JR; Liu KX; MacDonald SM; Abdelbaki MS
Pediatr Blood Cancer; 2022 Oct; 69(10):e29830. PubMed ID: 35686831
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome and methylome analysis of CNS germ cell tumor finds its cell-of-origin in embryogenesis and reveals shared similarities with testicular counterparts.
Takami H; Elzawahry A; Mamatjan Y; Fukushima S; Fukuoka K; Suzuki T; Yanagisawa T; Matsushita Y; Nakamura T; Satomi K; Tanaka S; Mukasa A; Saito N; Kanamori M; Kumabe T; Tominaga T; Kobayashi K; Nagane M; Iuchi T; Tamura K; Maehara T; Sugiyama K; Yoshimoto K; Sakai K; Nonaka M; Asai A; Yokogami K; Takeshima H; Narita Y; Shibui S; Nakazato Y; Hama N; Totoki Y; Kato M; Shibata T; Nishikawa R; Matsutani M; Ichimura K
Neuro Oncol; 2022 Aug; 24(8):1246-1258. PubMed ID: 35137206
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers for risk-based treatment modifications for CNS germ cell tumors: Updates on biological underpinnings, clinical trials, and future directions.
Takami H; Ichimura K
Front Oncol; 2022; 12():982608. PubMed ID: 36132131
[TBL] [Abstract][Full Text] [Related]
8. Isochromosome 12p and polysomy 12 in primary central nervous system germ cell tumors: frequency and association with clinicopathologic features.
Sukov WR; Cheville JC; Giannini C; Carlson AW; Shearer BM; Sinnwell JP; Ketterling RP
Hum Pathol; 2010 Feb; 41(2):232-8. PubMed ID: 19801160
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of intracranial non-germinomatous germ cell tumors: a retrospective Asian multinational study on treatment strategies and prognostic factors.
Hong KT; Han JW; Fuji H; Byun HK; Koh KN; Wong RX; Lee HL; Yoon HI; Lee JH; Phi JH; Kim SK; Kim DS; Lyu CJ; Choi JY; Kang HJ; Chen YW; Lee YY; Im HJ; Ra YS; Do Ahn S; Low SYY; Looi WS; Park HJ; Suh YG; Suh CO; Wang KC; Tan EEK; Wong TT; Kim JY
J Neurooncol; 2022 Oct; 160(1):41-53. PubMed ID: 36045266
[TBL] [Abstract][Full Text] [Related]
10. Brain and Spinal Tumors Originating from the Germ Line Cells.
Wong TT; Tsai ML; Chang H; Hsieh KL; Ho DM; Lin SC; Yen HJ; Chen YW; Lee HL; Yang TF
Adv Exp Med Biol; 2023; 1405():421-455. PubMed ID: 37452948
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic analysis of central nervous system germ cell tumors with comparative genomic hybridization.
Schneider DT; Zahn S; Sievers S; Alemazkour K; Reifenberger G; Wiestler OD; Calaminus G; Göbel U; Perlman EJ
Mod Pathol; 2006 Jun; 19(6):864-73. PubMed ID: 16607373
[TBL] [Abstract][Full Text] [Related]
12. [Evolving Exploration of the Pathogenesis of CNS Germ Cell Tumors with Regard to Precision Medicine].
Takami H; Takayanagi S; Tanaka S; Saito N
No Shinkei Geka; 2022 Jan; 50(1):39-50. PubMed ID: 35169085
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of distinctive imaging characteristics in primary intracranial germ cell tumors: A retrospective analysis.
Wang YF; Yang YL; Yang SH; Peng SS
J Formos Med Assoc; 2024 May; ():. PubMed ID: 38821737
[TBL] [Abstract][Full Text] [Related]
14. Histopathology of pineal germ cell tumors.
Vasiljevic A; Szathmari A; Champier J; Fèvre-Montange M; Jouvet A
Neurochirurgie; 2015; 61(2-3):130-7. PubMed ID: 24726316
[TBL] [Abstract][Full Text] [Related]
15. Impact of tumor markers on diagnosis, treatment and prognosis in CNS germ cell tumors: correlations with clinical practice and histopathology.
Takami H; Graffeo CS; Perry A; Giannini C; Nakazato Y; Saito N; Matsutani M; Nishikawa R; Daniels DJ; Ichimura K
Brain Tumor Pathol; 2023 Apr; 40(2):124-132. PubMed ID: 36995447
[TBL] [Abstract][Full Text] [Related]
16. Hypomethylated X chromosome gain and rare isochromosome 12p in diverse intracranial germ cell tumors.
Okada Y; Nishikawa R; Matsutani M; Louis DN
J Neuropathol Exp Neurol; 2002 Jun; 61(6):531-8. PubMed ID: 12071636
[TBL] [Abstract][Full Text] [Related]
17. Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy.
Murray MJ; Bailey S; Heinemann K; Mann J; Göbel UK; Saran F; Hale JP; Calaminus G; Nicholson JC
Int J Cancer; 2017 Aug; 141(3):621-635. PubMed ID: 28463397
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and immunohistochemical features of primary central nervous system germ cell tumors: a 24-years experience.
Gao Y; Jiang J; Liu Q
Int J Clin Exp Pathol; 2014; 7(10):6965-72. PubMed ID: 25400782
[TBL] [Abstract][Full Text] [Related]
19. Integrated clinical, histopathological, and molecular data analysis of 190 central nervous system germ cell tumors from the iGCT Consortium.
Takami H; Fukuoka K; Fukushima S; Nakamura T; Mukasa A; Saito N; Yanagisawa T; Nakamura H; Sugiyama K; Kanamori M; Tominaga T; Maehara T; Nakada M; Kanemura Y; Asai A; Takeshima H; Hirose Y; Iuchi T; Nagane M; Yoshimoto K; Matsumura A; Kurozumi K; Nakase H; Sakai K; Tokuyama T; Shibui S; Nakazato Y; Narita Y; Nishikawa R; Matsutani M; Ichimura K
Neuro Oncol; 2019 Dec; 21(12):1565-1577. PubMed ID: 31420671
[TBL] [Abstract][Full Text] [Related]
20. Multimodality treatment for Central Nervous System Germ Cell Tumors: Disease spectrum and management strategies - A tertiary care center experience from India.
Kumar N; Madan R; Dracham CB; Khosla D; Das N; Dey T; Elangovan A; Tripathi M; Gupta K; Ahuja CK; Kapoor R
Clin Neurol Neurosurg; 2021 Mar; 202():106481. PubMed ID: 33508649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]